Prediction of Survival in Resected Non–Small Cell Lung Cancer Using a Protein Expression–Based Risk Model: Implications for Personalized Chemoprevention and Therapy

Kathryn A. GoldEdward S. KimDiane D. LiuPing YuanCarmen BehrensLuisa M. SolisHumam KadaraDavid C. RiceIgnacio I. WistubaStephen G. Swisher2026-03-222026-03-22201310.1158/1078-0432.ccr-13-1959https://doi.org/10.1158/1078-0432.ccr-13-1959https://andeanlibrary.org/handle/123456789/45175Citaciones: 30We have developed a comprehensive risk model predictive for recurrence in our large retrospective database, which is one of the largest reported series of resected NSCLC.enImmunohistochemistryMedicineLung cancerInternal medicineOncologyProportional hazards modelCarcinogenesisCancerCancer researchPathologyPrediction of Survival in Resected Non–Small Cell Lung Cancer Using a Protein Expression–Based Risk Model: Implications for Personalized Chemoprevention and Therapyarticle